XM does not provide services to residents of the United States of America.

Alexandria Real Estate lifts annual FFO forecast on higher occupancy



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Alexandria Real Estate lifts annual FFO forecast on higher occupancy</title></head><body>

Oct 21 (Reuters) -Real estate investment trust Alexandria Real Estate Equities ARE.N beat Wall Street estimates for third-quarter funds from operations (FFO) on Monday, driven by higher occupancy.

Alexandria's occupancy of operating properties in North America as of Sept. 30 stood at 94.7%, compared with 93.7% a year earlier.

The Pasadena, California-based company operates and develops life science laboratories, offices and technology campuses across North America.

Its clients include Bristol-Myers Squibb BMY.N, Moderna MRNA.O and Eli Lilly LLY.N, as well as agricultural tech companies and research institutions.

Third-quarter adjusted FFO came in at $2.37 per share, above analysts' estimates of $2.33 per share, according to data compiled by LSEG.

Following an increase in healthcare research funding towards the end of the quarter — spurred by federal rate cuts — leasing demand for life sciences real estate is set to improve.

The life science REIT narrowed its full-year adjusted FFO to be in the range of $9.45 to $9.49 per share from an earlier forecast of $9.41 to $9.53 per share, maintaining a mid-point of $9.47, which is above analysts' average estimate of $9.31.

Alexandria's total revenue for the quarter rose nearly 11% to $791.6 million, compared with estimates of $766.7 million.



Reporting by Aatreyee Dasgupta in Bengaluru; editing by Alan Barona

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.